Skip to Content

Vivek Balasubramaniam, MD

Vivek Balasubramaniam, MD

Vivek Balasubramaniam, MD, Awarded NIH Funding with University of Kentucky

Posted: Feburary 5, 2015

Vivek Balasubramaniam, MD, will serve as a Co-Investigator/Subaward Principal Investigator for a grant from the National Institutes of Health/National Heart, Lung, and Blood Institute (NIH-NHLBI) to the University of Kentucky entitled, “Specific Lysis for Large-Volume, High-Purity Endothelial Progenitor Cell Isolates.” This 4-year R01 award to Principal Investigator Bradley Berron, PhD (University of Kentucky), develops a new approach to isolating a rare type of cell capable of repairing heart damage, which promises to deliver cells with fewer contaminants, faster, and at a lower cost than is possible today. This technology is also expected to both accelerate and reduce the cost of research across a broad spectrum of biological and medical sciences. Dr. Balasubramaniam’s role in the subaward, worth over $700,000 in direct costs, will be to perform the Endothelial Progenitor Cell (EPC) functionality studies in the proposal.


Ellen R. Wald, MD

Ellen R. Wald, MD

Ellen Wald, MD, Awarded NIH Funding with University of Pittsburgh

Posted: Feburary 5, 2015

Congratulations to Nader Shaikh, MD (University of Pittsburgh) and Ellen Wald, MD, Principal Investigators of a U01 grant from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH-NIAID). Their grant, entitled, “Efficacy of Antibiotics in Children with Sinusitis: Which Children Benefit?” is a 5-year award, in the amount of over $4.9 million in total costs. The objectives of this multi-site study are to determine which children diagnosed with acute sinusitis will benefit from antimicrobial therapy and if there are subgroups in which antibiotic therapy can be appropriately withheld based on symptoms. These objectives will be achieved by conducting a large, randomized, double-blind, placebo-controlled clinical trial in children 2 to 12 years of age with persistent or worsening presentations of acute sinusitis. Eliminating use of antibiotics in children for whom it is unnecessary and targeting only those children likely to benefit will constitute an important asset to both individual and public health.


Elizabeth M. Petty, MD

Elizabeth M. Petty, MD

Aaron L. Carrel, MD

Aaron L. Carrel, MD

Elizabeth Petty, MD, and Aaron Carrel, MD, Awarded Wisconsin Partnership Program Funding

Posted: February 5, 2016

Congratulations to Elizabeth Petty, MD (Principal Investigator) and Aaron Carrel, MD (Co-Investigator) for funding of their grant entitled, “Engaging Clinicians in Online Social Learning to Close Knowledge Gaps in Community Health: Pilot Focus on Obesity and Mental Health Care.” This two-year award, in the amount of $150,000 is from the Wisconsin Partnership Program Education and Research Committee (PERC). The goal of the project is to create an innovative interactive eLearning program, named My Lifelong Learning Online Communities (MyLLOCs) that combines online social learning modalities with traditional eLearning formats in order to improve access to high?quality and innovative interprofessional continuing education activities for primary care and other community?based health care providers across Wisconsin.


Pelin Cengiz, MD

Pelin Cengiz, MD

Pelin Cengiz, MD, Awarded ICTR Voucher Award

Posted: Feburary 5, 2015

Pelin Cengiz, MD, was awarded a grant from the UW Institute for Clinical and Translational Research (ICTR) in October for her proposal titled “Exploring a sex-based therapy: A novel approach for neuroprotection after neonatal brain injury”. This 2015 ICTR Voucher Award is a 6-month award in the amount of $7,500 that will provide laboratory support for Dr. Cengiz’ research at the UW Carbone Cancer Center Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics Laboratory (3P Lab).


Mario Otto, MD, PhD

Mario Otto, MD, PhD

Mario Otto, MD, PhD, Awarded Carbone Cancer Center Pilot Grant

Posted: Feburary 5, 2015

Congratulations to Mario Otto, MD, PhD, who was awarded a one-year pilot award from the UW Carbone Cancer Center (UWCCC) entitled, “TCRαβ+/CD19+ depleted HSCT + Zoledronate for Pediatric Cancers.” This $50,000 award ($40,000 from the program and an additional $10,000 supplement for Early Phase research) is supported by the Experimental Therapeutics (XT) program funded under the federally funded Cancer Center core grant. In this Phase I clinical stem cell transplantation (SCT) trial, Dr. Otto and co-investigators will use a special form of transplant, called haploidentical SCT, where a parent of the patient is the source of the stem cells. This will ensure that virtually every child has a stem cell donor immediately available. More importantly, the trial is based on a novel, pioneering stem cell engineering process that administers functioning immune cells, in addition to large numbers of stem cells, to the patient. Patients will be given the drug zoledronate to further activate the immune cells in their body. These immune cells could provide protection from life-threatening infection and prevent cancer recurrence early after the transplant procedure, thereby improving patient survival.


Sheryl L. Henderson, MD, PhD

Sheryl L. Henderson, MD, PhD

Sheryl Henderson, MD, PhD, Awarded Waisman Grant

Posted: Feburary 5, 2015

Congratulations to Sheryl L. Henderson, MD, PhD, who recently received a Youth Health Transition Quality Improvement Grant in the amount of $20,460, from the Waisman Center of the University of Wisconsin-Madison. Her one-year award, entitled “A Program for the Transition of Healthcare for HIV-Infected Youth,” will focus on transition policy, transition readiness, and monitoring and tracking for older youth with HIV as they transition from pediatric to adult care. Funds will also be used to assist with development of tools for education and transition readiness assessment for younger patients.


Pelin Cengiz, MD

Pelin Cengiz, MD

Study Led By Pelin Cengiz, MD, Examines Why Female Newborns are Better Protected from Brain Injury

Posted: Feburary 4, 2015

The Waisman Center lab of Pelin Cengiz, MD, published a study in the journal eNeuro focusing on why male infants are more vulnerable to hypoxic ischemic encephalopathy (HIE), a deprivation of oxygen and nutrient-rich blood caused by pregnancy or birth complications that can lead to learning disabilities, cerebral palsy or even death.

The research team showed that a particular protein, estrogen receptor α (ERα), found in the brains of both male and female mice, is present at higher levels in females, thereby offering them stronger protection against HIE. Better understanding this difference is a first step toward helping newborns of both sexes recover from HIE and live functional lives. It could also lead to more effective therapies and treatments for both genders.

Read the full story at wisc.edu


Daniel Sklansky, MD

Daniel Sklansky, MD

Daniel Sklansky, MD Receives WMAA Clinical Science Teaching Award

Posted: Feburary 3, 2015

Congratulations to Daniel Sklansky, MD, who has been chosen to receive the Wisconsin Medical Alumni Association’s (WMAA) Clinical Science Teaching Award. The award is given each hear to a clinical science teacher from Madison, La Crosse, Marshfield, and Milwaukee in recognition for dedicated commitment to teaching excellence. Dr. Sklansky was selected to receive the award based on a vote of the 4th year medical students. The award will be presented at the annual UW School of Medicine and Public Health’s Honors and Awards Ceremony on Thursday, May 12th.


M. Tracy Bekx, MD

M. Tracy Bekx, MD

M. Tracy Bekx, MD, Receives Waisman Grant

Posted: January 26, 2015

M. Tracy Bekx, MD received a Youth Health Transition Quality Improvement Grant in the amount of $20,250 from the Waisman Center of the University of Wisconsin- Madison. This one-year award, for her project entitled "Transition of Care in Adolescents with type 1 diabetes: teaching patients "The Keys" to drive their own diabetes," will focus on transition policy and readiness for teens with type 1 diabetes transitioning from pediatric to adult care.


Michael Rock, MD

Michael Rock, MD

Michael Rock, MD, Receives Grant for Cystic Fibrosis Center

Posted: January 26, 2015

Michael Rock, MD, was recently awarded an Additional Research Coordinator (ARC) Award from the Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT). This two-year award, in the amount of $177,755, will provide support for an additional research coordinator for the Cystic Fibrosis Center in Madison, including enrollment of subjects in both adult and pediatric clinical trials.


Kathleen Kelly Shanovich, NP

Kathleen Kelly Shanovich, NP

Kathleen Shanovich, NP, Awarded Asthma Grant

Posted: January 26, 2015

Congratulations to Kathleen Shanovich and collaborators with the AFCH Asthma Advocacy Program, Madison Metropolitan School District, and UW Health Pediatrics, who were awarded a Wisconsin Asthma Coalition mini grant in the amount of $9,995 for the project entitled, "Comprehensive asthma control through evidence-based strategies and public health-health care collaboration." This 11-month award will help provide asthma education/school management to new school nurses via a 3-hour educational program, as well as ongoing asthma support/case management to "seasoned" and new nurses. This mini grant would provide salary support for an allergy/asthma advanced practice nurse to coordinate this program, as well as funds to purchase asthma model airways for school nurses to use to provide asthma education to students.


Judith Smith, MD, PhD

Judith Smith, MD, PhD

Judith Smith, MD, PhD, Receives Graduate School Fall Competition Award

Posted: January 26, 2015

Congratulations to Judith Smith, MD, PhD, on her recent award of $75,460 from the UW Office of the Vice Chancellor for Research and Graduate Education. This one-year award for her project entitled, "Immunogenetics of axial Spondyloarthritis," will allow her lab to perform RNA sequencing to identify potential causal spondyloarthritis gene variants, and will also be used as a discovery platform to identify other dysregulated immune pathways in this disease.


Marlowe Eldridge, MD

Marlowe Eldridge, MD

Marlowe Eldridge, MD, Receives Graduate School Fall Competition Award

Posted: January 26, 2015

Marlowe Eldridge, MD, was awarded $65,761 for his project entitled, "Cardiac contractile function and glucose metabolism in postmenopausal women during exercise: Effects of estrogen." This one-year award from the UW Office of the Vice Chancellor for Research and Graduate Education will allow the use of a newly installed positron emission tomography/magnetic resonance (PET/MR) imager to simultaneously garner measures of cardiac metabolism and contractile function. His lab will employ a novel MR compatible exercise machine that will allow researchers to measure cardiac glucose metabolism and contractile function during exercise. This multidisciplinary approach is a novel way to obtain clinically relevant data and to better determine the role estrogen replacement in postmenopausal women has on cardiac metabolic and contractile processes.


Christian Capitini, MD

Christian Capitini, MD

Christian Capitini, MD, Receives Graduate School Fall Competition Award

Posted: January 26, 2015

Congratulations to Christian Capitini, MD, who was recently awarded a one-year grant from the UW Office of the Vice Chancellor for Research and Graduate Education for his project entitled, "Enhancing the graft-versus-tumor effect against neuroblastoma." This award, in the amount of $66,523, will allow his lab to study the use of allogenic bone marrow transplant models to optimize graft-versus-tumor effects against neuroblastoma without exacerbating graft-versus-host disease. Results of this proposal could provide a novel, targeted approach for treating neuroblastoma.


Monica Gressett

Monica Gressett

Monica Gressett Awarded Research Scholarship

Posted: January 26, 2015

Congratulations to Monica Gressett, student researcher in the lab of Paul Sondel, MD, PhD, who was recently awarded the Ann Haney Senior Honors Research Scholarship from the UW School of Letter and Sciences. She is mentored by Zachary Morris, MD, PhD, a PL3 resident in Radiation Oncology. She will receive the $2,500 scholarship this spring to fund her senior honors thesis, entitled: "The Effect of Radiation on Tumor Cell Susceptibility to Immune Response."


Thor Jeppson

Thor Jeppson

Thor Jeppson from PROKids Presents at National Dissemination and Implementation Conference

Posted: January 5, 2015

Thor Jeppson, research specialist for PROKids, recently presented at the 8th Annual Conference on the Science of Dissemination and Implementation in Health in Washington, DC. “Identifying barriers and solutions to research participation for chronically ill children and teens” is part of Dr. Elizabeth Cox’s PCORI-funded Project ACE, a randomized controlled trial of a family-centered intervention to improve diabetes self-management in children and adolescents. Jeppson and his co-authors describe how they used interviews and stakeholder advisory boards to identify barriers to trial participation for chronically ill children and adolescents. In addition to identifying barriers, this stakeholder engagement process also identified a variety of potential solutions to overcome those barriers. Organized by Academy Health and the National Institutes of Health, the Annual Conference is the largest national meeting on dissemination and implementation science.


Neonatology Researchers Receive $120,000 in Meriter Foundation Grants

Posted: December 30, 2015

Congratulations to five investigators from the Division of Neonatology & Newborn Nursery who were recently awarded nearly $120,000 in total funding from the Meriter Foundation Research and Education Grants Program. The awards will support four clinical research studies in 2016. The investigators and their projects are:

  • Pamela Kling, MD: Multifetal Gestation Pregnancies, Fetal Kidney Dysfunction and Programming of Life-Long BP ($30,000)
  • De-Ann Pillers, MD, PhD: Impact of Common neonatal drugs on Epithelial to Mesenchymal Transition in Lung Alveolar Cells ($30,000)
  • Bikash Pattnaik, PhD: Effect of Oxytocin on Retina Angiogenesis as a Measure of Retinopathy of Prematurity ($30,000)
  • Michael Porte, MD, and Cora Astorga, MD: Procalcitonin as a Biomarker in Detection of Early Onset Neonatal Sepsis Using Umbilical Cord Blood Analysis ($30,000)
Cora Astorga, MD

Cora Astorga, MD

Pamela Kling, MD

Pamela Kling, MD

Bikash Pattnaik, PhD

Bikash Pattnaik, PhD

De-Ann Pillers, MD, PhD

De-Ann Pillers, MD, PhD

Michael Porte, MD

Michael Porte, MD

     

Sarmila Basnet

Sarmila Basnet

Gern Lab Graduate Student Receives NIH Travel Award

Posted: December 30, 2015

Congratulations to Sarmila Basnet, graduate student in the lab of James Gern, MD, for receiving a travel award from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH-NIAID). She presented a poster at the NIH/NIAID Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) steering committee meeting held on November 3-4, 2015 in Rockville, MD. Her travel was funded by the NIAID AADCRC trainee travel program up to an amount of $1820.


Zulmarie Perez-Horta

Zulmarie Perez-Horta

Sondel Lab Graduate Student Receives Award

Posted: December 30, 2015

Zulmarie Perez-Horta, PhD student in the lab of Paul Sondel, MD, PhD, was a recent recipient of the First Place Award for Graduate Student Research for her research poster at the 2nd Annual Puerto Rico Cancer Conference. This one-day meeting, held in October, was designed to start a forum in the Island of Puerto Rico for the discussion of the most current findings in the cancer field, highlighting the latest and most exciting discoveries in every area of cancer research. Congratulations to Zulmarie!


Robert Strait, MD

Robert Strait, MD

Robert Strait, MD, Awarded Endocrine Fellows Foundation Research Grant

Posted: December 30, 2015

Congratulations to Robert Strait, MD, Endocrinology/Diabetes fellow, who was recently awarded an Endocrine Fellows Foundation (EFF) Research Grant in the amount of $5,000, funded by the EFF. This 1-year award, for his project entitled, "HPA axis activation by psychological stress as an independent risk factor for metabolic syndrome components in children", will shed additional light on the relationship between chronic stress, alterations in body composition, and laboratory markers of metabolic syndrome in children, and will for the first time in children link these findings to assessments of psychological stress. These data will add to understanding about predictive factors for metabolic disease, and will provide a foundation of preliminary data for prospective studies examining mindfulness training as an intervention to reduce chronic stress and metabolic morbidity in obese children.


Nasrollah (Nasr) Shahidi, MD

Nasrollah (Nasr) Shahidi, MD

Remembering Nasrollah Shahidi, MD, First Pediatric Hematology/Oncology Division Head

Posted: December 8, 2015

Nasrollah (Nasr) Shahidi, MD, emeritus professor of pediatrics, died on November 30, 2015. He was the first head of the University of Wisconsin Department of Pediatrics’ Division of Hematology and Oncology, a world leader in the understanding and care of bone marrow failure syndromes, and an influential mentor to many.

Born in what is now Iran, but what he would always refer to as Persia, Dr. Shahidi initially trained in Paris. He came to the U.S. in 1954 to complete a pediatrics residency at City Hospital in Baltimore, and later completed a postdoctoral fellowship in pediatric hematology at Harvard University, where he began his research career.

In 1966, Nathan Smith, MD, then-chair of the UW Department of Pediatrics, recruited Dr. Shahidi to create a new division of pediatric hematology and oncology at UW Medical School. Here, he built a strong clinical program, continued his laboratory and translational research, trained many students and residents, and established the division’s postdoctoral fellowship program.

Dr. Shahidi was a leader in the laboratory analysis and treatment of Fanconi anemia, a rare, inherited blood disorder that can lead to bone marrow failure and leukemia. He was the first to treat a child with the disease using an innovative therapy derived from umbilical cord stem cells, a modality that is now commonly used for children with a variety of blood disorders.

During his tenure, UW-Madison became one of the initial institutions to join the Cancer and Leukemia Group-B, an early multi-institutional consortium that evolved into the Children’s Cancer Group (CCG) and is now known as the Children’s Oncology Group (COG).

In addition, Dr. Shahidi was instrumental in identifying the blood-disease-causing roles of the antibiotics phenacetin and chloramphenicol, and the pesticide DDT, and directly influenced the restrictions on their use.

He authored several books and many highly regarded manuscripts, and earned an international reputation as an innovator in pediatric hematologic cancers.

His deep legacy at UW is carried on today through current division head, Dr. Paul Sondel. Dr. Shahidi helped to convince Dr. Sondel to join the UW faculty in 1980, and to succeed him as division head 10 years later.

“Dr. Shahidi was a remarkable physician-scientist, academician, leader, mentor, physician, and Renaissance man, with many diverse accomplishments and interests,” said Dr. Sondel. “He has influenced the careers of countless pediatric hematologists/oncologists around the country and the world. I am personally grateful to him for the ways he looked out for our faculty, our team, our program and our patients.”


Elizabeth Cox, MD, PhD

Elizabeth Cox, MD, PhD

Elizabeth Cox, MD, PhD, Consulting On Dr. Safdar’s PCORI-funded Research On Healthcare-Associated Infections

Posted: December 1, 2015

Dr. Elizabeth Cox will consult on new research on healthcare-associated infections (HAI), funded by the Patient-Centered Outcomes Research Institute (PCORI). Led by Dr. Nasia Safdar, Associate Chief of Staff for Research at the William S. Middleton VA Medical Center and Associate Professor in the Department of Medicine, the project will integrate patient perspectives to improve research on the prevention and treatment of HAIs. Along with Dr. Betty Chewning, Professor in the UW School of Pharmacy, Dr. Cox will provide expertise in stakeholder engagement and patient-centered outcomes research needed to create and sustain a blended stakeholder advisory panel—including patients and their families—who will participate in setting the agenda for future HAI research.


Past News & Announcements



Last updated: 02/04/2016
webmaster [at] pediatrics [dot] wisc [dot] edu
Copyright © 2016 The Board of Regents of the University of Wisconsin System